Literature DB >> 27104882

Unraveling molecular effects of ADAR1 overexpression in HEK293T cells by label-free quantitative proteomics.

Jisheng Guo1, Xiaoyue Wang1, Xin Lü1, Ruirui Jing1, Junqiang Li1, CuiLing Li1, Daoguang Wang1, Baibin Bi1, Xinjun Chen1, Fengqin Wang1, Shengnan Sun1, Jing Gong1, Kazem M Azadzoi2, Jing-Hua Yang1,2.   

Abstract

ADAR1 is a double-stranded RNA (dsRNA) editing enzyme that specifically converts adenosine to inosine. ADAR1 is ubiquitously expressed in eukaryotes and participate in various cellular processes such as differentiation, proliferation and immune responses. We report here a new proteomics study of HEK293T cells with and without ADAR1 overexpression. The up- and down-regulated proteins by ADAR1 overexpression are identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS) followed by label-free protein quantification. Totally 1,495 proteins (FDR < 0.01) are identified, among which 211 are up- and 159 are down-regulated for at least 1.5-fold (n = 3, p < 0.05). Gene ontology analysis reveals that these ADAR1-regulated proteins are involved in protein translation and cell cycle regulation. Bioinformatics analysis identifies a closely related network consistent for the protein translation machinery and a tightly connected network through proliferating cell nuclear antigen (PCNA)-interactions. Up-regulation of the proteins in the PCNA-mediated cell proliferation network is confirmed by Western blotting. In addition, ADAR1 overexpression is confirmed to increase cell proliferation in HEK293T cells and A549 cells. We conclude that ADAR1 overexpression modulates the protein translation and cell cycle networks through PCNA-mediated protein-protein interaction to promote cell proliferation in HEK293 cells.

Entities:  

Keywords:  ADAR1; biotechnology; cell proliferation; mass spectrometry; protein translation; proteomics

Mesh:

Substances:

Year:  2016        PMID: 27104882      PMCID: PMC4934060          DOI: 10.1080/15384101.2016.1176657

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  39 in total

1.  A novel PCNA-binding motif identified by the panning of a random peptide display library.

Authors:  H Xu; P Zhang; L Liu; M Y Lee
Journal:  Biochemistry       Date:  2001-04-10       Impact factor: 3.162

2.  Subcellular distribution of ADAR1 isoforms is synergistically determined by three nuclear discrimination signals and a regulatory motif.

Authors:  Yongzhan Nie; Qingchuan Zhao; Yingjun Su; Jing-Hua Yang
Journal:  J Biol Chem       Date:  2004-01-07       Impact factor: 5.157

3.  Expression patterns of LIS1, dynein and their interaction partners dynactin, NudE, NudEL and NudC in human gliomas suggest roles in invasion and proliferation.

Authors:  Satoshi O Suzuki; Richard J McKenney; Shin-ya Mawatari; Masashi Mizuguchi; Atsushi Mikami; Toru Iwaki; James E Goldman; Peter Canoll; Richard B Vallee
Journal:  Acta Neuropathol       Date:  2007-01-13       Impact factor: 17.088

4.  The Prp19/Pso4 core complex undergoes ubiquitylation and structural alterations in response to DNA damage.

Authors:  Xiaoyan Lu; Randy J Legerski
Journal:  Biochem Biophys Res Commun       Date:  2007-01-26       Impact factor: 3.575

5.  Hepatoma-derived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals.

Authors:  Yoshihiko Kishima; Hiroyasu Yamamoto; Yoshitaka Izumoto; Kenya Yoshida; Hirayuki Enomoto; Mitsunari Yamamoto; Toshifumi Kuroda; Hiroaki Ito; Kazuyuki Yoshizaki; Hideji Nakamura
Journal:  J Biol Chem       Date:  2001-12-18       Impact factor: 5.157

6.  Downregulation of the expression of HDGF attenuates malignant biological behaviors of hilar cholangiocarcinoma cells.

Authors:  Yanfeng Liu; Jingxian Sun; Guangyun Yang; Zhaojian Liu; Sen Guo; Rui Zhao; Kesen Xu; Xiaopeng Wu; Zhaoyang Zhang
Journal:  Mol Med Rep       Date:  2015-06-12       Impact factor: 2.952

7.  Expression of Ku80 correlates with sensitivities to radiation in cancer cell lines of the head and neck.

Authors:  Hyo Won Chang; Sang Yoon Kim; So-Lyoung Yi; Se-Hee Son; Do Young Song; Su Young Moon; Jong Hoon Kim; Eun Kyung Choi; Seung Do Ahn; Seong Soo Shin; Kang Kyoo Lee; Sang-Wook Lee
Journal:  Oral Oncol       Date:  2006-02-03       Impact factor: 5.337

8.  Depletion of the histone chaperone tNASP inhibits proliferation and induces apoptosis in prostate cancer PC-3 cells.

Authors:  Oleg M Alekseev; Richard T Richardson; James K Tsuruta; Michael G O'Rand
Journal:  Reprod Biol Endocrinol       Date:  2011-04-16       Impact factor: 5.211

9.  The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.

Authors:  Niamh M Mannion; Sam M Greenwood; Robert Young; Sarah Cox; James Brindle; David Read; Christoffer Nellåker; Cornelia Vesely; Chris P Ponting; Paul J McLaughlin; Michael F Jantsch; Julia Dorin; Ian R Adams; A D J Scadden; Marie Ohman; Liam P Keegan; Mary A O'Connell
Journal:  Cell Rep       Date:  2014-11-13       Impact factor: 9.423

10.  Exportin-5 mediates nuclear export of SRP RNA in vertebrates.

Authors:  Toshihiko Takeiwa; Ichiro Taniguchi; Mutsuhito Ohno
Journal:  Genes Cells       Date:  2015-02-04       Impact factor: 1.891

View more
  4 in total

Review 1.  RNA editing-dependent epitranscriptome diversity in cancer stem cells.

Authors:  Qingfei Jiang; Leslie A Crews; Frida Holm; Catriona H M Jamieson
Journal:  Nat Rev Cancer       Date:  2017-04-18       Impact factor: 60.716

2.  Proteomics Analysis Reveals an Important Role for the PPAR Signaling Pathway in DBDCT-Induced Hepatotoxicity Mechanisms.

Authors:  Yunlan Li; Xinxin Liu; Lin Niu; Qingshan Li
Journal:  Molecules       Date:  2017-07-06       Impact factor: 4.411

3.  Functionally selective activation of the dopamine receptor D2 is mirrored by the protein expression profiles.

Authors:  Deborah Wenk; Vladimir Ignatchenko; Andrew Macklin; Harald Hübner; Peter Gmeiner; Dorothée Weikert; Monika Pischetsrieder; Thomas Kislinger
Journal:  Sci Rep       Date:  2021-02-10       Impact factor: 4.379

4.  RNA Editing Therapeutics: Advances, Challenges and Perspectives on Combating Heart Disease.

Authors:  Maria Birgaoanu; Marco Sachse; Aikaterini Gatsiou
Journal:  Cardiovasc Drugs Ther       Date:  2022-10-14       Impact factor: 3.947

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.